In one paragraphArticle in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
24 authors.
Hannah M KortbawiDepartment of Biochemistry and Biophysics, University of California San Francisco; San Francisco, CA, USA.ORCID 0000-0002-6482-0724 Ryan J MarczakDepartment of Epidemiology and Biostatistics, University of California San Francisco; San Francisco, CA, USA.
Jayant V RajanDepartment of Biochemistry and Biophysics, University of California San Francisco; San Francisco, CA, USA.ORCID 0000-0002-6188-2284 Nash L BulaongChan Zuckerberg Biohub San Francisco; San Francisco, CA, USA.
Wesley WuChan Zuckerberg Biohub San Francisco; San Francisco, CA, USA.
Grace WangChan Zuckerberg Biohub San Francisco; San Francisco, CA, USA.
Anthea MitchellChan Zuckerberg Biohub San Francisco; San Francisco, CA, USA.
Aditi MaheshwariDepartment of Epidemiology and Biostatistics, University of California San Francisco; San Francisco, CA, USA.
Charles J FleischmannDepartment of Laboratory Medicine, University of California, San Francisco; San Francisco, CA, USA.ORCID 0000-0003-1501-4571 Emily A KellyDepartment of Laboratory Medicine, University of California, San Francisco; San Francisco, CA, USA.
Evan TealDepartment of Laboratory Medicine, University of California, San Francisco; San Francisco, CA, USA.ORCID 0000-0002-0422-0305 Rebecca L TownsendScientific Affairs, American Red Cross; Gaithersburg, MD, USA.
Emi E OkamotoNew York University School of Medicine; New York, NY, USA.
Eva H ClarkSection of Infectious Diseases, Department of Medicine, Baylor College of Medicine; Houston, TX, USA.ORCID 0000-0002-0350-8753 Rony ColanziUniversidad Catolica Boliviana; Santa Cruz, Plurinational State of Bolivia.
Efstathios D GennatasDepartment of Epidemiology and Biostatistics, University of California San Francisco; San Francisco, CA, USA.ORCID 0000-0001-9280-3609 Caryn BernDepartment of Epidemiology and Biostatistics, University of California San Francisco; San Francisco, CA, USA.ORCID 0000-0001-8195-7303 Joseph L DeRisiDepartment of Biochemistry and Biophysics, University of California San Francisco; San Francisco, CA, USA.ORCID 0000-0002-4611-9205 Jeffrey D WhitmanDepartment of Laboratory Medicine, University of California, San Francisco; San Francisco, CA, USA.ORCID 0000-0002-3502-5799 Funding
Host-parasite lipid metabolism in Trypanosoma cruzi-infected cardiac myocytesK38HL154203 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WHITMAN, JEFFREY DOMINICK · 2020 to 2021
$227kNHLBI NIH HHS K38 HL154203
6 · The paper itselfAbstract
Identifiers
PMID39974016
PMCPMC11838992
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390